COMPANY MISSION

Athericâ„¢ Pharmaceutical LLC is focused on rapid development and commercialization of re-purposed drugs to prevent and treat Zika, Yellow fever, other viral diseases and bio-threats.  Atheric's lead drug products are reformulated broad spectrum antiviral drugs that inhibit autophagy-dependent viral replication as well as other anti-viral pathways, and which may include preventing infection by mosquito-transmitted viruses .  Atheric is committed to providing broad-spectrum antiviral medical countermeasures. 

Click here for a downloadable one page, printable PDF on our corporation.


How Effective Does an Anti-Arbovirus Drug Need to Be?

Robert Malone, MD, MS, CEO/CSO of Atheric Pharmaceuticals, LLC, explains how effective a drug needs to be to generate protection.

Which Licensed Compounds Can Be Used Against Zika?

Robert Malone, MD, MS, CEO/CSO of Atheric Pharmaceuticals, LLC, discusses which existing licensed drug compounds are able to be repurposed for use against Zika.